Mineralys Therapeutics
MLYS
#5780
Rank
A$1.82 B
Marketcap
A$20.64
Share price
-3.53%
Change (1 day)
-68.17%
Change (1 year)

EPS for Mineralys Therapeutics (MLYS)

EPS in 2026 (TTM): A-$6.32

According to Mineralys Therapeutics's latest financial reports the company's current EPS (TTM) is A-$6.59. In 2025 the company made an earnings per share (EPS) of A-$3.58 an increase over its 2024 EPS that were of A-$5.50.

EPS history for Mineralys Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$6.3276.52%
2025A-$3.58-34.89%
2024A-$5.50
2022A-$6.40